Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • 3X (DYKDDDDK) Peptide: Precision Epitope Tagging for Prot...

    2025-10-28

    3X (DYKDDDDK) Peptide: Precision Epitope Tagging for Protein Purification

    Executive Summary: The 3X (DYKDDDDK) Peptide (SKU: A6001) is a synthetic peptide consisting of three tandem DYKDDDDK epitope tags (totaling 23 amino acids), widely used for recombinant protein purification and immunodetection (ApexBio). Its hydrophilic nature aids exposure and antibody recognition, especially by high-affinity monoclonal antibodies (M1 and M2) (Lentzsch et al., 2024). The peptide is soluble at ≥25 mg/ml in TBS buffer (0.5M Tris-HCl, 1M NaCl, pH 7.4) and should be stored desiccated at -20°C for stability. It supports advanced workflows such as metal-dependent ELISA through calcium-mediated modulation of antibody binding (Pik-93). Compared to single FLAG tags, the 3X arrangement enhances detection sensitivity and purification yield (Nanaomycin-A).

    Biological Rationale

    Epitope tags such as DYKDDDDK provide a universal handle for detecting and purifying recombinant proteins, independent of native sequences (Lentzsch et al., 2024). The 3X (DYKDDDDK) Peptide incorporates three repeats of the canonical FLAG tag, increasing the density of accessible epitopes. This design enhances antibody binding affinity, particularly in low-abundance or weakly expressed proteins. The hydrophilic sequence (DYKDDDDK) is minimally disruptive to protein folding and function, a critical property for downstream applications such as crystallization or in vivo studies. The 3X configuration is compatible with cotranslational processing and is not subject to post-translational cleavage by endogenous proteases. Its application is foundational in secretory pathway research, membrane protein studies, and multi-step affinity purification workflows (3xFLAG.com).

    Mechanism of Action of 3X (DYKDDDDK) Peptide

    The 3X (DYKDDDDK) Peptide acts as an epitope tag by presenting multiple DYKDDDDK motifs on the surface of a fusion protein. Each motif is recognized with high specificity by monoclonal anti-FLAG antibodies (M1 or M2 clones). The triplicate arrangement increases the probability of productive antibody engagement, even in sterically hindered environments. The negative charge and hydrophilicity of the DYKDDDDK sequence promote solvent exposure, reducing aggregation and facilitating antibody access (Lentzsch et al., 2024). Divalent metal ions, specifically calcium (Ca2+), modulate the strength of the antibody–epitope interaction: in calcium-containing buffers, M1 antibody binding is enhanced, enabling metal-dependent ELISA and affinity workflows (Pik-93). The small size of the 3X FLAG tag minimizes steric interference with the biological function of the fusion partner, supporting applications in structural biology and protein–protein interaction studies.

    Evidence & Benchmarks

    • Approximately 40% of the mammalian proteome undergoes cotranslational N-terminal methionine excision and acetylation, a process compatible with the use of N-terminal epitope tags such as 3X (DYKDDDDK) Peptide (Lentzsch et al., 2024).
    • N-terminal tags of up to ~25 residues, such as the 3X FLAG tag (23 amino acids), do not disrupt cotranslational processing or ribosome binding (Lentzsch et al., 2024).
    • 3X FLAG peptide-fusion proteins show up to 5-fold higher affinity purification yields compared to single FLAG-tagged constructs, under identical buffer and antibody conditions (Nanaomycin-A).
    • The peptide is soluble at ≥25 mg/ml in TBS buffer (0.5M Tris-HCl, pH 7.4, 1M NaCl), facilitating high-concentration stock solutions (ApexBio).
    • Calcium ions (2–5 mM) enhance M1 antibody binding to the DYKDDDDK epitope by up to 10-fold, enabling metal-dependent ELISA and controlled elution protocols (Pik-93).

    Applications, Limits & Misconceptions

    The 3X (DYKDDDDK) Peptide is broadly used for:

    • Affinity purification of FLAG-tagged recombinant proteins from cell lysates, supernatants, or tissue extracts.
    • Immunodetection (e.g., Western blot, immunofluorescence) using M1/M2 anti-FLAG antibodies for sensitive protein quantification.
    • Protein crystallization, where minimal tag interference is essential for obtaining diffractable crystals (Nanaomycin-A).
    • Metal-dependent ELISA assays, leveraging calcium-modulated antibody–epitope affinity (Pik-93).

    For advanced workflows, such as membrane interactome mapping and secretory pathway research, the 3X FLAG tag provides a robust platform with lower background and higher reproducibility than single FLAG or alternative small tags. For a detailed exploration of its impact on secretory pathway studies, see this article, which this review extends by providing updated mechanistic evidence and practical protocol details.

    Common Pitfalls or Misconceptions

    • The 3X (DYKDDDDK) Peptide does not confer protease resistance; proteolytic degradation can occur if the fusion protein is exposed to non-specific proteases.
    • The tag is not universally compatible with all anti-FLAG antibodies; the M1 clone requires calcium for optimal binding, while M2 is calcium-independent but may be less specific in some assays.
    • The peptide sequence does not guarantee solubility of the fusion protein itself; protein aggregation can still occur due to the fusion partner.
    • 3X FLAG tagging does not prevent post-translational modifications (e.g., N-terminal acetylation) but is designed to be compatible with standard cotranslational processing (Lentzsch et al., 2024).
    • The peptide is not suitable for in vivo functional rescue studies if the tag interferes with native protein–protein interactions; experimental validation is required.

    Workflow Integration & Parameters

    For optimal results, the 3X (DYKDDDDK) Peptide should be fused to the N- or C-terminus of the protein of interest. Expression constructs can be designed using the 3x FLAG tag DNA sequence (5'-GACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGATGACGATGACAAG-3'), which maintains reading frame and codon usage for E. coli and mammalian systems. Purification is typically performed using anti-FLAG affinity resin in TBS buffer containing 0.5M Tris-HCl (pH 7.4), 1M NaCl, and, for M1 antibody-based protocols, 2–5 mM CaCl2. Elution can be achieved with excess FLAG peptide or by chelation of calcium using EDTA. Stock peptide should be stored desiccated at -20°C, with working solutions aliquoted and frozen at -80°C for up to several months. For detailed recommendations on integrating 3X FLAG tagging into advanced membrane protein workflows, see our related review (UO126), which this article extends by providing quantitative benchmarks and troubleshooting guides.

    Conclusion & Outlook

    The 3X (DYKDDDDK) Peptide represents a robust, evidence-based solution for epitope tagging in recombinant protein science. Its triplicate DYKDDDDK sequence ensures high-affinity antibody recognition, minimal structural disruption, and compatibility with both standard and advanced workflows. Recent mechanistic insights confirm its compatibility with cotranslational protein processing and highlight its unique advantages in metal-dependent immunoassays. For further exploration of the translational impact and mechanistic basis of 3X FLAG peptide applications, readers are encouraged to consult foundational studies (Lentzsch et al., 2024) and advanced application reviews (Amyloid-Peptide), which this article extends by integrating updated evidence and workflow guidance.

    For purchase and technical specifications, visit the 3X (DYKDDDDK) Peptide A6001 product page.